150 related articles for article (PubMed ID: 11094304)
21. BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer.
Gershoni-Baruch R; Dagan E; Fried G; Kepten I; Robinson E
Eur J Hum Genet; 1999; 7(7):833-6. PubMed ID: 10573018
[TBL] [Abstract][Full Text] [Related]
22. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
Roa BB; Boyd AA; Volcik K; Richards CS
Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
[TBL] [Abstract][Full Text] [Related]
23. BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma.
Bruchim I; Amichay K; Kidron D; Attias Z; Biron-Shental T; Drucker L; Friedman E; Werner H; Fishman A
Int J Gynecol Cancer; 2010 Oct; 20(7):1148-53. PubMed ID: 21206239
[TBL] [Abstract][Full Text] [Related]
24. An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews.
Lalloo F; Cochrane S; Bulman B; Varley J; Elles R; Howell A; Evans DG
J Med Genet; 1998 Jan; 35(1):10-2. PubMed ID: 9475087
[TBL] [Abstract][Full Text] [Related]
25. Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.
Wolf I; Laitman Y; Rubinek T; Abramovitz L; Novikov I; Beeri R; Kuro-O M; Koeffler HP; Catane R; Freedman LS; Levy-Lahad E; Karlan BY; Friedman E; Kaufman B
Oncogene; 2010 Jan; 29(1):26-33. PubMed ID: 19802015
[TBL] [Abstract][Full Text] [Related]
26. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women.
Karp SE; Tonin PN; Bégin LR; Martinez JJ; Zhang JC; Pollak MN; Foulkes WD
Cancer; 1997 Aug; 80(3):435-41. PubMed ID: 9241077
[TBL] [Abstract][Full Text] [Related]
27. A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer.
Lu KH; Cramer DW; Muto MG; Li EY; Niloff J; Mok SC
Obstet Gynecol; 1999 Jan; 93(1):34-7. PubMed ID: 9916952
[TBL] [Abstract][Full Text] [Related]
28. Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel.
Rennert G; Dishon S; Rennert HS; Fares F
Eur J Cancer Prev; 2005 Aug; 14(4):357-61. PubMed ID: 16030426
[TBL] [Abstract][Full Text] [Related]
29. Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls.
Muto MG; Cramer DW; Tangir J; Berkowitz R; Mok S
Cancer Res; 1996 Mar; 56(6):1250-2. PubMed ID: 8640808
[TBL] [Abstract][Full Text] [Related]
30. Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.
Fishman A; Dekel E; Chetrit A; Lerner-Geva L; Bar-Am A; Beck D; Beller U; Ben-Baruch G; Piura B; Friedman E; Struewing JP; Modan B
Gynecol Oncol; 2000 Oct; 79(1):74-8. PubMed ID: 11006035
[TBL] [Abstract][Full Text] [Related]
31. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
[TBL] [Abstract][Full Text] [Related]
32. Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors.
Gotlieb WH; Friedman E; Bar-Sade RB; Kruglikova A; Hirsh-Yechezkel G; Modan B; Inbar M; Davidson B; Kopolovic J; Novikov I; Ben-Baruch G
J Natl Cancer Inst; 1998 Jul; 90(13):995-1000. PubMed ID: 9665148
[TBL] [Abstract][Full Text] [Related]
33. Predominant Ashkenazi BRCA1/2 mutations in families with pancreatic cancer.
Dagan E
Genet Test; 2008 Jun; 12(2):267-71. PubMed ID: 18439109
[TBL] [Abstract][Full Text] [Related]
34. Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation.
Bernholtz S; Laitman Y; Kaufman B; Paluch Shimon S; Friedman E
Breast Cancer Res Treat; 2011 Sep; 129(2):557-63. PubMed ID: 21499684
[TBL] [Abstract][Full Text] [Related]
35. Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
Lee JS; Wacholder S; Struewing JP; McAdams M; Pee D; Brody LC; Tucker MA; Hartge P
J Natl Cancer Inst; 1999 Feb; 91(3):259-63. PubMed ID: 10037104
[TBL] [Abstract][Full Text] [Related]
36. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds.
Berman DB; Wagner-Costalas J; Schultz DC; Lynch HT; Daly M; Godwin AK
Am J Hum Genet; 1996 Jun; 58(6):1166-76. PubMed ID: 8651293
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer.
Schubert EL; Mefford HC; Dann JL; Argonza RH; Hull J; King MC
Genet Test; 1997; 1(1):41-6. PubMed ID: 10464624
[TBL] [Abstract][Full Text] [Related]
38. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
Berman DB; Costalas J; Schultz DC; Grana G; Daly M; Godwin AK
Cancer Res; 1996 Aug; 56(15):3409-14. PubMed ID: 8758903
[TBL] [Abstract][Full Text] [Related]
39. Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations.
Ramus SJ; Fishman A; Pharoah PD; Yarkoni S; Altaras M; Ponder BA
Eur J Surg Oncol; 2001 Apr; 27(3):278-81. PubMed ID: 11373105
[TBL] [Abstract][Full Text] [Related]
40. Methylenetetrahydrofolate reductase (MTHFR): the incidence of mutations C677T and A1298C in the Ashkenazi Jewish population.
Rady PL; Tyring SK; Hudnall SD; Vargas T; Kellner LH; Nitowsky H; Matalon RK
Am J Med Genet; 1999 Oct; 86(4):380-4. PubMed ID: 10494095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
